This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...